Editorial
Revisiting interactions between hypoxaemia and
2
agonists in asthma
| The first 150 words of the full text of this article appear below. |
The excessive use of
2 agonists has been
associated with increased asthma mortality, although this seems to be
due to confounding by disease severity rather than direct drug
toxicity.1 2 Dose-response studies in stable asthmatics
have shown the potential for high doses of salbutamol to produce direct
or indirect cardiovascular sequelae mediated by extrapulmonary
2 adrenoceptor stimulation including chronotropic and
inotropic activity, peripheral vasodilatation, electrocardiographic
changes, as well as hypokalaemia and hypomagnesaemia.3 4
The potential for cardiovascular toxicity with high doses of inhaled
2 agonists may be considered in the context of "the seed and the soil". In terms of the "seed", there are conflicting reports as to whether a full agonist such as fenoterol produces greater
dose related systemic
2 mediated systemic effects than a
partial agonist such as salbutamol in asthmatic patients when comparing
microgram equivalent doses with the same bronchodilator potency.4-6 In terms of the "soil" for salbutamol
mediated adverse effects, concomitant diuretic
This article has been cited by other articles:
-
Salpeter, S. R., Ormiston, T. M., Salpeter, E. E.
(2004). Cardiovascular Effects of {beta}-Agonists in Patients With Asthma and COPD: A Meta-Analysis. Chest
125: 2309-2321
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
